GSK Amends Paxil Label With Increased Risk of Suicide Warning In Young Adults
This article was originally published in The Pink Sheet Daily
Executive Summary
Meta-analysis finds that paroxetine-treated patients ages 18-24 have an increased risk of suicidality.
You may also be interested in...
FDA Approves Antidepressant "Black Box" Class Labeling
The revised labeling should be available on manufacturers' web pages within two weeks and on all products within 30 days, FDA says. Medication Guides should be available to pharmacists by Jan. 31, the agency says.
NEJM, JAMA Editorials Give Opposing Opinions Of Mandatory HPV Vaccination
Two of the leading medical journals are offering opposing viewpoints on mandatory human papilloma virus vaccination, with experts contributing perspective pieces that directly reflect the larger political and social division over the issue
FDA’s Arcoxia Decision Offers New Evidence Of Conservative Review Stance
FDA's "not approvable" action on Merck's Vioxx follow-on Arcoxia for the treatment of symptoms of osteoarthritis could be indicative of a conservative regulatory climate at the agency